NUS up +0.76% percent Today $NUS High is at 40.48 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
NUS up +0.76% percent Today $NUS High is at 40.48 and the Low 39.30 with current volume of 258,227.

Recent News posted below.

Nu Skin Enterprises NUS other info.
http://investorshangout.com/Nu-Skin-Enterprises-NUS-52125/

NUS Nu Skin Enterprises Recent Headline News

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Nu Skin Enterprises Is Down 10.0% (NUS)
Comtex SmarTrend(R) - 1 hr 14 mins ago
When Nu Skin Enterprises (NYSE:NUS) reported earnings a week ago on November 5th, 2014, analysts, on average, expected the company to report earnings of $0.92 on sales of $629.2 million. The company actually reported EPS of $1.12 on sales of $638.8 million, beating EPS estimates by $0.20 and beating revenue estimates by $9.6 million. Shares of Nu Skin Enterprises have slipped from $43.76 to $39.40, representing a loss of 10.0%, since the company reported earnings 12 days ago.
NUS: 38.93 (-0.47)

Nu Skin Enterprises (NUS) Downgraded From Buy to Hold
at The Street - Fri Nov 14, 8:45AM CST
Nu Skin Enterprises (NUS) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
NUS: 38.93 (-0.47)

The Nu Skin Disaster Continues
Mohan Venigalla - Seeking Alpha - Tue Nov 11, 5:00AM CST
I have been following Nu Skin (NYSE: NUS ) for several months and have written a handful of articles about NUS on Seeking Alpha ( here , here , here and here ). Before the market opened on Nov. 5th, 2014 NUS released earnings for FY-3Q ending...
HLF: 38.57 (+0.07), NUS: 38.93 (-0.47)

Quarterly Financial Results, Appointments, and Legal Updates - Research Reports on US Steel, Oasis Petroleum, GoPro, Nu Skin and PMI
PR Newswire - Mon Nov 10, 8:20AM CST
Today, Analysts Review released its research reports regarding United States Steel Corp. (NYSE: X), Oasis Petroleum Inc. (NYSE: OAS), GoPro, Inc. (NASDAQ: GPRO), Nu Skin Enterprises Inc. (NYSE: NUS) and Philip Morris International, Inc. (NYSE: PM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7811-100free.
PM: 87.20 (+0.92), GPRO: 82.50 (+3.35), NUS: 38.93 (-0.47), X: 36.29 (+0.05), OAS: 25.80 (-0.75)

Herbalife Or Nu Skin: Which Controversial Company Posted Stronger Quarterly Results?
Joey Solitro - at Seeking Alpha - Mon Nov 10, 4:50AM CST

HLF: 38.57 (+0.07), NUS: 38.93 (-0.47)

Herbalife: Keeping Up Appearances
Rogier van Vlissingen - Seeking Alpha - Sat Nov 08, 11:51AM CST
Herbalife (NYSE: HLF ) is garnering some more unwanted exposure amid the recent slide in the stock. Pershing Square have sent a masterful letter to Pamela Harbor Jones , who is in charge of something called "compliance" at Herbalife....
PRI: 51.72 (-0.33), HLF: 38.57 (+0.07), AVP: 10.03 (-0.04), NUS: 38.93 (-0.47), USNA: 109.53 (-0.92), MTEX: 23.00 (+2.69)

Personal Products Stocks Coverage - Avon Products, Nu Skin Enterprises, Herbalife, Coty, and Estee Lauder Cos.
PR Newswire - Fri Nov 07, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Avon Products Inc. (NYSE: AVP), Nu Skin Enterprises Inc. (NYSE: NUS), Herbalife Ltd (NYSE: HLF), Coty Inc. (NYSE: COTY), and The Estee Lauder Companies Inc. (NYSE: EL). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 06, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,554.47, up 0.40% and the NASDAQ Composite closed at 4,638.47, up 0.38%. The S&P 500 finished the session 0.38% higher at 2,031.21. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Consumer Staples Sector Index ended the day at 489.76, up 0.20%, with the index advancing 8.73% in the previous three months. Register for your complimentary reports on these five stocks at:
HLF: 38.56 (+0.06), AVP: 10.03 (-0.04), COTY: 19.01 (-0.14), NUS: 38.93 (-0.47), EL: 71.08 (-0.25)

Nu Skin Beats Q3 Earnings; Cuts View on Weak Y/Y Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:00PM CST
Nu Skin Enterprises Inc (NUS) reported better-than-expected results in the third quarter of 2014. However, the results were significantly lower than the prior-year quarter, which led the company to reduce its outlook for the fourth quarter of 2014.
HELE: 63.25 (+0.03), LB: 77.86 (+0.38), NUS: 38.93 (-0.47), CTRN: 22.24 (-0.43)

NYSE stocks posting largest percentage decreases
AP - Thu Nov 06, 12:17PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
HLF: 38.56 (+0.06), BPI: 10.94 (-0.32), CZZ: 8.76 (-0.24), TCAP: 22.24 (-0.30), ESI: 9.75 (-0.63), NSM: 28.74 (+0.04), NUS: 38.93 (-0.47), WAC: 16.62 (+0.03), VSLR: 11.47 (-0.46), SWC: 13.14 (-0.03), LPX: 14.74 (+0.13), SSNI: 7.75 (-0.30), GNW: 9.34 (-0.07), KOP: 29.15 (-0.38)

Weakness Seen in Nu Skin Enterprises (NUS): Stock Tumbles 13.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 7:30AM CST
Nu Skin Enterprises saw a big move last session, as the company’s shares fell by over 13% on the day.
HELE: 63.25 (+0.03), CSV: 19.66 (+0.19), NUS: 38.93 (-0.47), PPC: 31.31 (+0.92)

Nu Skin announces quarterly dividend of USD0.345 per share
M2 - Thu Nov 06, 4:39AM CST
The board of directors of Nu Skin Enterprises Inc (NYSE:NUS), a skin care and nutrition company, approved a quarterly dividend of USD0.345 per share, the company declared on Wednesday.
NUS: 38.93 (-0.47)

Nu Skin plunges on Q4 outlook
at Investor's Business Daily - Wed Nov 05, 5:49PM CST
Shares of the maker of anti-aging skincare products sunk 13.2% to 43.76 following disappointing Q4 guidance. Nu Skin Enterprises' (NUS) Q3 EPS fell 37.8% to $1.12, above views by 20 cents, and revenue sank 31.1% to $638.8 mil, topping forecasts for...
NUS: 38.93 (-0.47)

After Yesterday's Decline of 13.21%, Nu Skin Enterprises Offers Investors Better Value
Comtex SmarTrend(R) - Wed Nov 05, 4:00PM CST
Nu Skin Enterprises (NYSE:NUS) traded in a range yesterday that spanned from a low of $39.46 to a high of $44.63. Yesterday, the shares fell 13.2%, which took the trading range below the 3-day low of $49.28 on volume of 9.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NUS: 38.93 (-0.47)

Devon Energy and Activision are big market movers
AP - Wed Nov 05, 3:23PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
HLF: 38.56 (+0.06), DVN: 63.96 (-0.22), MDLZ: 38.14 (-0.02), DISCB: 38.87 (-0.08), DISCA: 32.63 (-0.90), CHUY: 21.69 (-0.08), ROSE: 36.22 (-1.02), COUP: 16.10 (-0.41), ATVI: 20.07 (-0.03), DISCK: 31.74 (-0.58), S: 4.91 (-0.14), CHK: 23.52 (+0.31), NUS: 38.93 (-0.47), ODP: 6.70 (-0.09), CVX: 115.86 (-0.46)

Nu Skin Enterprises' (NUS) CEO Truman Hunt on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 1:20PM CST

NUS: 38.93 (-0.47)

Nu Skin Investors Wrinkle Noses At Weak Q4 Guidance
at Investor's Business Daily - Wed Nov 05, 12:07PM CST
Nu Skin Enterprise (NUS) shares are plummeting as the maker of anti-aging skincare products offered up disappointing fourth-quarter revenue and earnings guidance. Shares of the company had fallen more than 15% to 42.60 by early afternoon trading in...
HLF: 38.56 (+0.06), NUS: 38.91 (-0.49)

Nu Skin Enterprises (NUS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:55AM CST

NUS: 38.91 (-0.49)

Nu Skin's Q4 Outlook Has Sent Shares Plummeting By More Than 12%, Should You Be A Buyer?
Joey Solitro - at Seeking Alpha - Wed Nov 05, 9:51AM CST

NUS: 38.91 (-0.49)

Nu Skin Enterprises tumbles on 4Q outlook
AP - Wed Nov 05, 9:48AM CST
NEW YORK (AP) — Share of Nu Skin Enterprises Inc. dropped Wednesday after the company offered a weak forecast for the fourth quarter, as its sales in China have slumped following a government investigation.
NUS: 38.91 (-0.49)

Nu Skin Enterprises Inc. (NUS) Stock Research Links

NUS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 21

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 66

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 150

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 7

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 38

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 180

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 65

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 110

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharvaris Shares Promising Data on Deucrictibant Efficacy

Updated Category News Views 186

Pharvaris Highlights Clinical Progress in HAE Treatment At the recent AAAAI/WAO Joint Congress, Pharvaris presented compelling long-term clinical data supporting the use of deucrictibant, a novel oral treatment for hereditary angioedema (HAE). This data underscores the drug's potential to not only prevent but also effectively address HAE attacks, offering hope to those...

Continue Reading
First Horizon Opens New Banking Center Celebrating Local Pride

Updated Category News Views 349

First Horizon Unveils New Banking Center with Appalachian Spirit First Horizon Bank (NYSE: FHN) proudly celebrated the grand opening of its newly refreshed banking center. The location pays tribute to the vibrant Appalachian State community, showcasing a striking theme that reflects its strong ties with Appalachian State University and its athletics. This celebration...

Continue Reading
Understanding Namodenoson's Role in Liver Cancer and Beyond

Updated Category News Views 243

Innovative Research on Namodenoson’s Impact in Liver Cancer Therapy Namodenoson, developed by Can-Fite BioPharma Ltd., is making waves in the medical community as a promising candidate for liver cancer treatment. Unlike traditional chemotherapy, which often harms healthy cells, Namodenoson is lauded for its protective qualities towards normal body systems. Published...

Continue Reading
Geotab Enhances Public Sector Solutions with Technological Advancements

Updated Category News Views 147

Geotab Enhances Public Sector Solutions with Technological Advancements Geotab Inc., a leader in connected vehicle solutions and asset management, has taken a major step forward in serving the public sector by expanding its cooperative purchasing contracts with Sourcewell and Canoe Procurement Group. This expansion introduces four cutting-edge solutions aimed at enhancing...

Continue Reading
Dun & Bradstreet Earns TRUSTe Certification for Responsible AI

Updated Category News Views 351

Dun & Bradstreet Achieves TRUSTe Responsible AI Certification Dun & Bradstreet (NYSE:DNB), recognized globally as a leading provider of business decisioning data and analytics, has been awarded the TRUSTe Responsible AI Certification. This certification signifies the company’s commitment to ethical and responsible governance in the realm of artificial intelligence (AI)....

Continue Reading